Vansen Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VANSEN PHARMA, and what generic and branded alternatives to VANSEN PHARMA drugs are available?
VANSEN PHARMA has one approved drug.
Drugs and US Patents for Vansen Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vansen Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | 5,958,915 | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | 4,839,350 | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | 5,958,915 | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | 4,839,350 | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | 4,918,068 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.